ETF Managers Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $172K | Buy |
16,647
+4,209
| +34% | +$43.6K | 0.01% | 597 |
|
|
2022
Q4 | $147K | Sell |
12,438
-2,276
| -15% | -$26.9K | 0.01% | 486 |
|
|
2022
Q3 | $309K | Sell |
14,714
-1,160
| -7% | -$24.4K | 0.01% | 552 |
|
|
2022
Q2 | $485K | Buy |
15,874
+555
| +4% | +$17K | 0.01% | 500 |
|
|
2022
Q1 | $640K | Sell |
15,319
-941
| -6% | -$39.3K | 0.01% | 419 |
|
|
2021
Q4 | $734K | Sell |
16,260
-3,286
| -17% | -$148K | 0.01% | 412 |
|
|
2021
Q3 | $1.01M | Buy |
19,546
+3,741
| +24% | +$194K | 0.02% | 269 |
|
|
2021
Q2 | $1.01M | Sell |
15,805
-521
| -3% | -$33.4K | 0.02% | 273 |
|
|
2021
Q1 | $1.47M | Sell |
16,326
-9,452
| -37% | -$853K | 0.03% | 229 |
|
|
2020
Q4 | $2.39M | Buy |
25,778
+6,203
| +32% | +$575K | 0.05% | 182 |
|
|
2020
Q3 | $2.04M | Buy |
19,575
+9,270
| +90% | +$967K | 0.06% | 157 |
|
|
2020
Q2 | $777K | Buy |
+10,305
| New | +$777K | 0.03% | 210 |
|